Interested in working at OHSU Knight Cancer Institute? We have a billion reasons!
OHSU is a nationally recognized health and research university. We bring together patient care, research, education of the next generation of health care providers and scientists and community service to improve the health and well-being of all Oregonians and people around the world. The Knight Cancer Institute at OHSU is an international leader in cancer research and precision treatment. The institute's director, Brian Druker, M.D., helped usher in the era of precision cancer medicine with research that led to the breakthrough drug Gleevec®.
- The institute is the only National Cancer Institute (NCI)-designated Cancer Center between Sacramento and Seattle —an honor earned only by the nation's top cancer centers.
- It is also the headquarters for the NCI's SWOG collaborative, a cancer research cooperative group that designs and conducts multidisciplinary clinical trials to improve the practice of medicine.
The Knight Cancer Institute has attracted both public support and private philanthropy to build upon its scientific and clinical leadership. Most recently, The OHSU Knight Cancer Institute announced that it has met the $1 billion Knight Cancer Challenge, issued in September 2013 by Phil and Penny Knight. The money will go toward advancing research to fight cancer at its earliest stages and detect the disease before it spreads.
The Knight Cancer Institute is also attracting powerful research collaborations with technology leaders such Intel Corporation and FEI Co., who want to be part of the Knight's mission to end cancer as we know it.
OHSU’s Knight Cancer Institute is fast-tracking the recruitment of 250 to 300 scientists and physician investigators — led by two dozen or more of the world's top cancer researchers — to unite behind a single, powerful vision to transform cancer care.
Position postings (iRecruitment, search under job categories faculty, research or others as applicable)